Browse resources

Topic: Disease/vaccine specific information

Total results with these characteristics: 952

Page 10 of 39  
‹ prev.
7
8
9
10
11
12
13
next ›

Epidemiology, Aetiology and Management of Childhood Acute Community-Acquired Pneumonia in Developing Countries--A Review

This article, published in the African Journal of Medicine and Medical Sciences, provides an overview of the causes of clinical pneumonia in developing countries, available vaccines for fighting pneumonia, and efforts underway and planned to expand …

Author: Falade AG, Ayede AI

Published: 2011

Epidemiology and Burden of Disease from Japanese Encephalitis in Cambodia: Results From Two Years of Sentinel Surveillance

This article, published in Tropical Medicine & International Health, describes the results of two years of surveillance for Japanese encephalitis (JE) disease in Cambodian children aged 15 years and under at six sentinel …

Author: Touch S, Hills S, Sokhal B, et al.

Published: 2009

Epidemiology of Bacterial Meningitis in Niamey, Niger, 1981-96

This study, published in the Bulletin of the World Health Organization, used retrospective surveillance to identify cases of laboratory-diagnosed bacterial meningitis in Niamey, Niger, from 1981 to 1996. The study analyzed the cases …

Author: Campagne G, Schuchat A, Djibo S, et al.

Published: 1999

Epidemiology of Japanese encephalitis in Context With Indian Scenario

This article provides a historical overview of Japanese encephalitis (JE) in India since the first detection of JE virus activity in 1952 until the 2006 introduction of JE vaccine in high-risk states and expansion of vaccination efforts in …

Author: Dhillon GP, Raina VK

Published: 2008

The Epidemiology of JE

This slide presentation gives an overview of the epidemiology of JE and can be adapted for individual use.

Author: PATH

Published: 2007

The Epidemiology of Meningococcal Disease and the Impact of Vaccines

Neisseria meningitidis causes meningococcal disease, a severe bacterial infection of the bloodstream or meninges, worldwide. The disease is most common among young children, but the existing polysaccharide vaccines have been sparsely used because …

Author: Khatami A, Pollard AJ

Published: 2010

Epidemiology of Meningococcal Disease in Latin America: Current Situation and Opportunities for Prevention

This article, published in Neurological Research, discusses the changes in the epidemiology of meningococcal disease in Latin America and comments on the development and potential impact of new vaccines for the prevention of the disease. The authors …

Author: Sáfadi MA, Cintra OA

Published: 2010

Escherichia coli Infections

This web page provides general information on Escherichia coli bacteria and symptoms of disease. It also includes links to other World Health Organization web pages related to E. coli.

Author: World Health Organization

Essential Training Package for HPV Vaccine Introduction for Countries Introducing Cervarix™ 2 Dose Vaccine

These eight training modules relate to key aspects of the introduction of the human papillomavirus (HPV) vaccine Cervarix™. They are intended for use by health workers during vaccine introduction training sessions and contain facilitator notes …

Author: World Health Organization

Published: 2013

Establishment of a New Human Pneumococcal Standard Reference Serum 007sp

This article, published in Clinical and Vaccine Immunology, reports on a study that resulted in the development of a new pneumococcal reference serum to replace the dwindling stocks of Lot 89SF, the reference standard serum pool used since 1990. The …

Author: Goldblatt D, Plikaytis BD, Akkoyunlu M, et al.

Published: 2011

Estimated Global Mortality Associated With the First 12 Months of 2009 Pandemic Influenza A H1N1 Virus Circulation: A Modelling Study

This article, published in The Lancet Infectious Diseases, estimates the global mortality associated with the first 12 months of the 2009 influenza A/H1N1 virus pandemic. Results of the analysis estimate that respiratory and cardiovascular …

Author: Dawood FS, Iuliano AD, Reed C, et al.

Published: 2012

Estimated Hib and Pneumococcal Deaths for Children Under 5 Years of Age, 2008

This web page provides an estimate of child mortality due to Haemophilus influenzae type b (Hib) and pneumococcal infections in 2008. It also contains a link to a chart of death rates due to these infections, broken down by region and HIV status.

Author: World Health Organization

Published: 2013

Estimates of World-Wide Distribution of Child Deaths From Acute Respiratory Infections

To establish a relation between deaths due to acute respiratory infections (ARI) and all-cause deaths in children under 5 years we show that the proportion of deaths directly attributable to ARI declines from 23% to 18% and then 15% (95% confidence …

Author: Williams B, Gouws E, Boschi-Pinto C, Bryce J, Dye C

Published: 2002

Estimating Age-Specific Cumulative Incidence for the 2009 Influenza Pandemic: A Meta-analysis of A(H1N1)pdm09 Serological Studies From 19 Countries

This article, published in Influenza and Other Respiratory Viruses, details the results of a meta-analysis conducted to provide insights into the global impact of the 2009 influenza A(H1N1) pandemic. The study estimates overall and age-specific …

Author: Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW

Published: 2013

Estimating the Burden of Pneumococcal Pneumonia Among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

This article, published in PLOS One, summarizes a study to develop a conceptual and quantitative strategy for estimating the non-bacteremic disease burden among adults with community-acquired pneumonia. The authors conclude that the adult burden of …

Author: Said MA, Johnson HL, Nonyane BAS, Deloria-Knoll M, O′Brien KL

Published: 2013

Estimating the Protective Concentration of Anti-pneumococcal Capsular Polysaccharide Antibodies

Published in the journal Vaccine, this article describes a method for correlating pneumococcal anticapsular antibody responses of infants immunized with pneumococcal conjugate (PnC) vaccine (Prevenar) with clinical protection from invasive …

Author: Siber G, Chang I, Baker S, et al.

Published: 2007

Estimation of the Potential Overall Impact of Human Papillomavirus Vaccination on Cervical Cancer Cases and Deaths

This article, published in Vaccine, reports on a study that aimed to estimate the potential real-life impact of the AS04-adjuvanted HPV-16/18 vaccine on cervical cancer cases and deaths at the country level. The authors found that HPV vaccination …

Author: Van Kriekinge G, Castellsagué X, Cibula D, Demarteau N

Published: 2014

Evaluaciónde Costo-Efectividad de la Vacuna Anti-rotavirus en Chile

This article, published in Revista Médica de Chile, outlines an economic model that determined rotavirus vaccination is a cost-effective intervention that can effectively reduce the disease burden and healthcare costs of rotavirus …

Author: Constenla D, O'Ryan M, Navarrete M, Antil L, Rheingans R

Published: 2006

Evaluating Clinical Trial Data and Guiding Future Research for Rotavirus Vaccines

This article, published in the Weekly Epidemiological Record, discusses the outcome of a meeting of global, regional, and country-level rotavirus experts and immunization opinion leaders who gathered to provide guidance on evaluating and …

Author: World Health Organization

Published: 2008

Evaluating HPV Vaccination Pilots: Practical Experience From PATH

From 2006 to 2011, PATH conducted human papillomavirus (HPV) vaccination demonstration projects in India, Peru, Uganda, and Vietnam to provide evidence for decision-making about public-sector introduction of HPV vaccines. This report provides …

Author: PATH

Published: 2012

Evaluation of Anatomic Changes in Young Children with Natural Rotavirus Infection: Is Intussusception Biologically Plausible?

This study, published in the Journal of Infectious Diseases, explores the biological plausibility of intussusception caused by natural rotavirus infection.

Author: Robinson C, Hernanz-Schulman M, Zhu Y, et al.

Published: 2004

Evaluation of Cost-Effectiveness of Live Oral Pentavalent Reassortant Rotavirus Vaccine Introduction in Ghana

This article, published in Vaccine, estimates the cost-effectiveness of introducing the rotavirus vaccine RotaTeq® in Ghana. The authors estimated the average costs of treating children with diarrhea in the Ashanti region of Ghana as inpatients …

Author: Abbott C, Tiede B, Armah G, Mahmoud A

Published: 2012

Evaluation of Meningitis Surveillance Before Introduction of Serogroup A Meningococcal Conjugate Vaccine—Burkina Faso and Mali

Before the 2010 to 2011 introduction of the first serogroup A meningococcal conjugate vaccine developed solely for Africa (MenAfriVac), evaluations of the existing meningitis surveillance in Burkina Faso and Mali were conducted to assess the …

Author: US Centers for Disease Control and Prevention

Published: 2012

Evaluation of Out-of-the-cold-chain Approaches for Improving On-time Delivery of the Hepatitis B Birth Dose in Rural Areas of China

This document summarizes the results of a study of out-of-the-cold-chain approaches for improving on-time delivery of birth doses of the hepatitis B vaccine in rural areas of China. The study concluded that this is a safe and effective way to …

Author: PATH

Published: 2005

Evaluation of Serogroup A Meningococcal Vaccines in Africa: A Demonstration Project

This article, published in The Journal of Health, Population, and Nutrition, summarizes the general steps required for meningococcal vaccine development, reviews the use of immunogenicity criteria as a licensing strategy for new meningococcal …

Author: Soriano-Gabarró M, Rosenstein N, LaForce FM

Published: 2004

Page 10 of 39  
‹ prev.
7
8
9
10
11
12
13
next ›